WebCorrespondence to: Hideharu Kimura, MD, PhD. Respiratory Medicine, Kanazawa University Hospital, Takara-machi 13-1, Kanazawa, Ishikawa, Japan. Email: [email protected]. Background: Molecular targeted therapy has been developed as an innovative treatment for metastatic cancer. WebBackgroundCo-mutations was associated with poor response to EGFR-TKIs. First-generation EGFR-TKIs combined with chemotherapy was reported to be more effective than TKIs alone in advanced lung adenocarcinoma patients.ObjectiveThis retrospective study aimed to explore whether EGFR-mutant patients with co-mutations can benefit from …

Loop Hidehito Kimura

WebIntroduction. Neuroendocrine carcinoma of the lung, which accounts for about 15–20% of primary lung cancer, is divided into four categories: small-cell lung cancer (SCLC), typical carcinoid, atypical carcinoid, and large-cell neuroendocrine carcinoma (LCNEC) (1, 2).Pulmonary large-cell and small-cell neuroendocrine carcinomas are classified as high … WebOf the patients, 1.5% (46/3077) had co-occurring potentially targetable oncogenic drivers. The characteristics of these patients were shown in Table 2. These patients are commonly seen in females (70 vs 30%), non-smokers (76 vs 24%), and adenocarcinomas (89 vs 11%). 80% (37/46) had EGFR mutations and other concomitant potentially actionable ... dr p gogineni

Hikaru Kawamura - IMDb

Web18 mar 2024 · Tamura Hideharu is a writer, born 1969 in Hokkaido. He has written as a reporter for the Asahi Shimbun, Bungei Shunju and AERA. He graduated from the … WebHideharu Kimura Mitsuhiro Imaizumi Current institution Showa Denko K. K. Business Development Tokyo, Japan Current position Senior Researcher Join ResearchGate to … dr phan kokomo indiana